Skip to content

Insider · CIK 0002013617

Ruben A Garcia

officer

Files at FBLG (FibroBiologics, Inc.). First filing Dec 12, 2025, latest Mar 2, 2026.

Ruben A Garcia files SEC Form 4 as officer at FBLG (FibroBiologics, Inc.). Since Dec 12, 2025, Ruben A Garcia has reported 2 open-market buys worth $61k and 0 open-market sells worth $0, the latest filed on Mar 2, 2026.

A track record needs three past buys with six months of prices behind them; Ruben A Garcia has 0, so none is measured yet.

The newest scored trade: bought $13k of FBLG on Feb 27, 2026, filed Mar 2, 2026, scored 49 (moderate). In the last 12 months: 2 buys worth $61k and 0 sells worth $0.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
2 / 0
$61k bought, $0 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

FBLG: FibroBiologics, Inc.

FBLGOct 9, 2026 · close 1.13

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
49Moderate
FBLGbuy 4
FibroBiologics, Inc.
$13k
40,000 shares
+29%+46% from low-76% from high
30Weak
FBLGbuy
FibroBiologics, Inc.
$48k
140,000 shares
--

Transactions

Every row this insider has filed, 5 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
May 4, 2026FBLG
FibroBiologics, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+61,607$0.00$061,607May 4, 2026
Feb 27, 2026FBLG
FibroBiologics, Inc.
POpen-market purchase
Common Stock
+40,000$0.33$13k180,000Mar 2, 2026
Dec 11, 2025FBLG
FibroBiologics, Inc.
POpen-market purchase
Common Stock
+140,000$0.34$48k140,000Dec 12, 2025
Mar 26, 2025FBLG
FibroBiologics, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+189,000$0.00$0189,000Mar 28, 2025
Dec 27, 2024FBLG
FibroBiologics, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+176,200$0.00$0176,200Dec 30, 2024

Questions about Ruben A Garcia

Answered from the filings on this page, as of the latest one.

Is Ruben A Garcia buying or selling?

In the last 12 months Ruben A Garcia reported 2 open-market buys worth $61k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $13k of FBLG on Feb 27, 2026. Grants, option exercises and tax withholding are not counted.

How did Ruben A Garcia's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Ruben A Garcia has 0.

Where does Ruben A Garcia file Form 4?

Ruben A Garcia has filed Form 4 at FBLG (FibroBiologics, Inc.) as General Counsel. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.